UBS Group’s ProShares Ultra Health Care RXL Stock Holding History

UBS Group’s Portfolio RXL Stock Details RXL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$590	Buy	+10	New	+$578	﹤0.01%	10557
2026 Q1	–	Sell	-161	Closed	-$8.34K	–	11073
2025 Q4	$8.34K	Sell	161 -11	-6%	-$537	﹤0.01%	8371
2025 Q3	$7.31K	Sell	172 -188	-52%	-$7.61K	﹤0.01%	8731
2025 Q2	$14.6K	Buy	+360	New	+$14.8K	﹤0.01%	8644
2025 Q1	–	Sell	-83	Closed	-$3.65K	–	10652
2024 Q4	$3.65K	Sell	83 -1,295	-94%	-$65K	﹤0.01%	8846
2024 Q3	$77.1K	Buy	1,378 +1,348	+4,493%	+$73.4K	﹤0.01%	6538
2024 Q2	$1.53K	Buy	+30	New	+$1.49K	﹤0.01%	8559
2024 Q1	–	Sell	-488	Closed	-$22.3K	–	9921
2023 Q4	$22.3K	Buy	+488	New	+$20.4K	﹤0.01%	7041
2022 Q4	–	Sell	-1,642	Closed	-$63K	–	11079
2022 Q3	$63K	Buy	1,642 +1,640	+82,000%	+$72.3K	﹤0.01%	6125
2022 Q2	$0	Buy	+2	New	+$92	﹤0.01%	10847

Other funds holding RXL

Elevate Capital Advisors Eagle, Colorado $174M AUM 12.7% 1-Year Est. Return

IMC Chicago Chicago, Illinois $483B AUM 41.26% 1-Year Est. Return

Toth Financial Advisory Leesburg, Virginia $1B AUM 19.18% 1-Year Est. Return

Atria Investments Charlotte, North Carolina $10.3B AUM 19.62% 1-Year Est. Return

FAI Advisors Farmington Hills, Michigan $257M AUM 20.66% 1-Year Est. Return

Capital Investment Advisory Services Raleigh, North Carolina $1.61B AUM 16.94% 1-Year Est. Return

Hantz Financial Services Southfield, Michigan $7.48B AUM 14.09% 1-Year Est. Return

Huntington National Bank Columbus, Ohio $20.5B AUM 28.07% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

UBS Group's RXL Position: Q3 2026 in Review

UBS Group opened a new position in ProShares Ultra Health Care (RXL) in Q3 2026: 10 shares worth $590. The stake represents ﹤0.01% of the portfolio and ranks #10557 among its holdings. This is a return to the name: UBS Group previously reported a position in RXL as recently as Q4 2025.

UBS Group first reported a position in RXL in Q2 2022 and has held it in 10 quarters since. The position peaked at $77.1K in Q3 2024. 9 funds tracked by Wall St. Rank hold RXL as of Q3 2026.

UBS Group held 10 shares of ProShares Ultra Health Care worth $590 as of Q3 2026.
ProShares Ultra Health Care was a new UBS Group position in Q3 2026.
ProShares Ultra Health Care made up ﹤0.01% of UBS Group's portfolio in Q3 2026, its #10557 holding.
UBS Group first reported a position in ProShares Ultra Health Care in Q2 2022 and has held it in 10 quarters since.
UBS Group's ProShares Ultra Health Care position peaked at $77.1K in Q3 2024.
9 funds tracked by Wall St. Rank held ProShares Ultra Health Care as of Q3 2026.

Based on UBS Group's 13F filing for Q3 2026, filed 10 Nov 2026.